In‐depth investigation of p53 pathway abnormalities not only contributes to elucidating the molecular mechanisms underlying renal cancer but also provides new insights and potential therapeutic targets for the diagnosis and treatment of this malignancy. Here, TP53 is linked to renal carcinoma.